Antifungal susceptibility testing (AST) has come to establish itself as a mandatory routine in
clinical practice. At the same time, the mycological diagnosis seems to have headed in the …

The increasing incidence and changing epidemiology of invasive fungal infections continue
to present many challenges to their effective management. The repertoire of antifungal drugs …

Background Invasive fungal diseases, including those caused by (multi) drug-resistant
Candida and Aspergillus species, still represent global public health concerns. Information …

Despite improvement of antifungal therapies over the last 30 years, the phenomenon of
antifungal resistance is still of major concern in clinical practice. In the last 10 years the …

Antifungal drug resistance: do molecular methods provide a w... : Current Opinion in Infectious
Diseases Antifungal drug resistance: do molecular methods provide a way forward? : Current …

Invasive mould infections due to Aspergillus spp., Fusarium spp., Scedosporium spp. and
other filamentous fungi remain a significant cause of morbidity and mortality in …

From the publisher's website: Infections caused by pathogenic fungi are a significant global
problem: a situation exacerbated by the limited availability of good antifungal options. Being …

The antifungal treatment failures and the emergence of resistant fungal strains have
stimulated the need for reproducible and clinically relevant antifungal susceptibility testing …

A collection of state-of-the-art molecular methods for studying antifungal resistance, for
discovering and evaluating both new and existing antifungal drugs, and for understanding …

Opportunistic fungal pathogens can cause a diverse range of diseases in humans. The
increasing rate of fungal infections caused by strains that are resistant to commonly used …